DAVID BOURGEOIS: Open Payments
NPI 1255909602 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 29 payments from 7 companies in 2025. Trend: 2023 $222 · 2024 $335 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 4 | $186 |
| Amgen Inc. | 13 | $158 |
| Boston Scientific Corporation | 5 | $122 |
| SCPHARMACEUTICALS INC. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Lilly USA, LLC | 1 | $20 |
Products named: REPATHA, SAPIEN 3 Ultra RESILIA, WATCHMAN FLX, FUROSCIX, LEQVIO, WATCHMAN Access System, VERQUVO, VersaCross Access Solution.
Industry payments across LA — which companies pay providers there.
